EUROFINS SCIENT Revenue 2018-2024 | ERFSF

EUROFINS SCIENT annual/quarterly revenue history and growth rate from 2018 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • EUROFINS SCIENT revenue for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • EUROFINS SCIENT revenue for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • EUROFINS SCIENT annual revenue for 2024 was $7.522B, a 6.68% increase from 2023.
  • EUROFINS SCIENT annual revenue for 2023 was $7.051B, a 0.3% decline from 2022.
  • EUROFINS SCIENT annual revenue for 2022 was $7.072B, a 11.02% decline from 2021.
EUROFINS SCIENT Annual Revenue
(Millions of US $)
2024 $7,522
2023 $7,051
2022 $7,072
2021 $7,948
2020 $6,213
2019 $5,110
2018 $4,466
2017 $3,359
2016 $2,762
2015 $0
EUROFINS SCIENT Quarterly Revenue
(Millions of US $)
2024-12-31
2024-06-30
2023-06-30
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $13.598B $7.522B
Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $138.024B 25.89
CVS Health (CVS) United States $80.885B 10.05
Elevance Health (ELV) United States $75.961B 9.80
Cencora (COR) United States $57.110B 19.87
DiDi Global (DIDIY) China $25.792B 27.40
Labcorp Holdings (LH) United States $20.561B 16.68
Natera (NTRA) United States $20.462B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
CochLear (CHEOY) Australia $12.760B 0.00
Solventum (SOLV) United States $12.748B 13.49
ICON (ICLR) Ireland $11.757B 10.93
Revvity (RVTY) United States $11.304B 19.45
Viatris (VTRS) United States $10.481B 3.60
Medpace Holdings (MEDP) United States $8.988B 23.87
Sonic Healthcare (SKHHY) Australia $8.788B 0.00
Avantor (AVTR) United States $8.736B 12.69
HealthEquity (HQY) United States $8.317B 36.43
Charles River Laboratories (CRL) United States $7.584B 14.86
Caris Life Sciences,�Inc (CAI) United States $7.355B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.851B 28.56
BrightSpring Health Services (BTSG) United States $3.527B 32.35
Sotera Health (SHC) United States $3.230B 18.35
Surgery Partners (SGRY) United States $2.799B 36.40
Alignment Healthcare (ALHC) United States $2.623B 0.00
Concentras Parent (CON) United States $2.543B 14.70
Organon (OGN) United States $2.485B 2.64
GeneDx Holdings (WGS) United States $2.331B 89.77
Progyny (PGNY) United States $1.992B 43.85
Ardent Health (ARDT) United States $1.991B 8.49
PACS (PACS) United States $1.897B 0.00
Premier (PINC) United States $1.719B 13.05
GoodRx Holdings (GDRX) United States $1.697B 33.93
Teladoc Health (TDOC) United States $1.388B 0.00
Establishment Labs Holdings (ESTA) $1.285B 0.00
Pediatrix Medical (MD) United States $1.100B 8.37
CareDx (CDNA) United States $1.058B 16.53
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.911B 0.00
QDM (QDMI) Hong Kong, SAR China $0.848B 291.00
AMN Healthcare Services Inc (AMN) United States $0.761B 7.13
Nutex Health (NUTX) United States $0.632B 9.57
InnovAge Holding (INNV) United States $0.564B 0.00
Embecta (EMBC) United States $0.560B 3.77
SBC Medicals (SBC) United States $0.511B 0.00
LifeMD (LFMD) United States $0.497B 0.00
Sonida Senior Living (SNDA) United States $0.473B 0.00
Auna S.A (AUNA) Luxembourg $0.472B 10.63
Omada Health (OMDA) $0.463B 0.00
So-Young (SY) China $0.455B 0.00
Enhabit (EHAB) United States $0.354B 29.17
COMPASS Pathways (CMPS) United Kingdom $0.333B 0.00
Performant Healthcare (PHLT) United States $0.309B 0.00
Oncology Institute (TOI) United States $0.265B 0.00
Beauty Health (SKIN) United States $0.207B 0.00
DocGo (DCGO) United States $0.142B 23.17
Pheton Holdings (PTHL) China $0.136B 0.00
Sera Prognostics (SERA) United States $0.102B 0.00
Ascend Wellness Holdings (AAWH) United States $0.072B 0.00
KindlyMD (NAKA) United States $0.071B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Basel Medical Group (BMGL) Singapore $0.047B 0.00
Biodesix (BDSX) United States $0.045B 0.00
ModivCare (MODV) United States $0.045B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
SeaStar Medical Holding (ICU) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00